Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Bioactive Ingredients in Rice (Oryza sativa L.) Function in the Prevention of Type 2 Diabetes.

Ina S, Hamada A, Kumagai H, Yamaguchi Y.

J Nutr Sci Vitaminol (Tokyo). 2019;65(Supplement):S113-S116. doi: 10.3177/jnsv.65.S113.

2.

Exclusive breast-feeding and postnatal changes in blood sodium, ketone, and glucose levels.

Futatani T, Ina S, Shimao A, Higashiyama H, Fujita S, Igarashi N, Hatasaki K.

Pediatr Int. 2019 May;61(5):471-474. doi: 10.1111/ped.13824. Epub 2019 May 14.

PMID:
30854754
3.

Fetal closed head injuries following maternal motor vehicle accident: A clinicopathologic case report.

Nishida N, Ina S, Hata Y, Nakanishi Y, Ishizawa S, Futatani T.

Medicine (Baltimore). 2018 Nov;97(44):e13133. doi: 10.1097/MD.0000000000013133.

4.

Suppressive Effect of the α-Amylase Inhibitor Albumin from Buckwheat (Fagopyrum esculentum Moench) on Postprandial Hyperglycaemia.

Ninomiya K, Ina S, Hamada A, Yamaguchi Y, Akao M, Shinmachi F, Kumagai H, Kumagai H.

Nutrients. 2018 Oct 15;10(10). pii: E1503. doi: 10.3390/nu10101503.

5.

Clinically diverse phenotypes and genotypes of patients with branchio-oto-renal syndrome.

Unzaki A, Morisada N, Nozu K, Ye MJ, Ito S, Matsunaga T, Ishikura K, Ina S, Nagatani K, Okamoto T, Inaba Y, Ito N, Igarashi T, Kanda S, Ito K, Omune K, Iwaki T, Ueno K, Yahata M, Ohtsuka Y, Nishi E, Takahashi N, Ishikawa T, Goto S, Okamoto N, Iijima K.

J Hum Genet. 2018 May;63(5):647-656. doi: 10.1038/s10038-018-0429-8. Epub 2018 Mar 2.

PMID:
29500469
6.

Capillary Blood Ketone Levels as an Indicator of Inadequate Breast Milk Intake in the Early Neonatal Period.

Futatani T, Shimao A, Ina S, Higashiyama H, Fujita S, Ueno K, Igarashi N, Hatasaki K.

J Pediatr. 2017 Dec;191:76-81. doi: 10.1016/j.jpeds.2017.08.080.

PMID:
29173326
7.

Virus myocarditis in a 1-month-old boy presenting as two types of paroxysmal supraventricular tachycardia.

Fujita S, Futatani T, Kubo T, Itamochi M, Yachi Y, Iwasaki H, Shimao A, Ina S, Higashiyama H, Igarashi N, Hatasaki K.

Pediatr Int. 2017 May;59(5):627-632. doi: 10.1111/ped.13261. Epub 2017 Apr 12.

PMID:
28402006
8.

Rice (Oryza sativa japonica) Albumin Suppresses the Elevation of Blood Glucose and Plasma Insulin Levels after Oral Glucose Loading.

Ina S, Ninomiya K, Mogi T, Hase A, Ando T, Matsukaze N, Ogihara J, Akao M, Kumagai H, Kumagai H.

J Agric Food Chem. 2016 Jun 22;64(24):4882-90. doi: 10.1021/acs.jafc.6b00520. Epub 2016 Jun 6.

9.

Effects of a mat pilates program on cardiometabolic parameters in elderly women.

Marinda F, Magda G, Ina S, Brandon S, Abel T, Ter Goon D.

Pak J Med Sci. 2013 Apr;29(2):500-4.

10.

Left atrium thrombus in an extremely low-birthweight infant with late-onset circulatory dysfunction.

Ina S, Futatani T, Higashiyama H, Hashida N, Fujita S, Shimura S, Igarashi N, Hatasaki K.

Pediatr Int. 2012 Aug;54(4):555-8. doi: 10.1111/j.1442-200X.2011.03531.x.

PMID:
22830547
11.

Intraneural metastasis of gastric carcinoma leads to sciatic nerve palsy.

Ichikawa J, Matsumoto S, Shimoji T, Tanizawa T, Gokita T, Hayakawa K, Aoki K, Ina S, Kanda H.

BMC Cancer. 2012 Jul 25;12:313. doi: 10.1186/1471-2407-12-313.

12.

A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy.

Kiyotani K, Uno S, Mushiroda T, Takahashi A, Kubo M, Mitsuhata N, Ina S, Kihara C, Kimura Y, Yamaue H, Hirata K, Nakamura Y, Zembutsu H.

Pharmacogenet Genomics. 2012 Apr;22(4):229-35. doi: 10.1097/FPC.0b013e32834e9eba. Erratum in: Pharmacogenet Genomics. 2014 Oct;24(10):530.

PMID:
22293537
13.

Annexin A2 in amniotic fluid: correlation with histological chorioamnionitis, preterm premature rupture of membranes, and subsequent preterm delivery.

Namba F, Ina S, Kitajima H, Yoshio H, Mimura K, Saito S, Yanagihara I.

J Obstet Gynaecol Res. 2012 Jan;38(1):137-44. doi: 10.1111/j.1447-0756.2011.01651.x. Epub 2011 Sep 28.

PMID:
21955246
14.

Commotio Cordis presenting as a temporary complete atrioventricular block in a 2-year-old girl with congenitally corrected transposition of the great arteries.

Fujita S, Nakamura T, Koura U, Toga A, Ina S, Higashiyama H, Futatani T, Shimura S, Igarashi N, Hatasaki K.

Pediatr Cardiol. 2011 Oct;32(7):1043-7. doi: 10.1007/s00246-011-0062-1. Epub 2011 Jul 28.

PMID:
21796443
15.

MUC1 is a useful molecular marker for malignant intraductal papillary mucinous neoplasms in pancreatic juice obtained from endoscopic retrograde pancreatography.

Shimamoto T, Tani M, Kawai M, Hirono S, Ina S, Miyazawa M, Shimizu A, Uchiyama K, Yokoyama S, Tsutsumi M, Yamaue H.

Pancreas. 2010 Aug;39(6):879-83. doi: 10.1097/MPA.0b013e3181d6ba04.

PMID:
20357691
16.

A prospective randomized controlled trial of internal versus external drainage with pancreaticojejunostomy for pancreaticoduodenectomy.

Tani M, Kawai M, Hirono S, Ina S, Miyazawa M, Shimizu A, Yamaue H.

Am J Surg. 2010 Jun;199(6):759-64. doi: 10.1016/j.amjsurg.2009.04.017. Epub 2010 Jan 15.

PMID:
20074698
17.

A role for IL-17 in induction of an inflammation at the fetomaternal interface in preterm labour.

Ito M, Nakashima A, Hidaka T, Okabe M, Bac ND, Ina S, Yoneda S, Shiozaki A, Sumi S, Tsuneyama K, Nikaido T, Saito S.

J Reprod Immunol. 2010 Jan;84(1):75-85. doi: 10.1016/j.jri.2009.09.005. Epub 2009 Dec 6.

PMID:
19969371
18.
19.

Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome-wide expression profiling.

Hirono S, Yamaue H, Hoshikawa Y, Ina S, Tani M, Kawai M, Ushijima M, Matsuura M, Saiki Y, Saiura A, Yamamoto J, Miki Y, Noda T.

Cancer Sci. 2010 Jan;101(1):259-66. doi: 10.1111/j.1349-7006.2009.01359.x. Epub 2009 Sep 10.

20.

How do we predict the clinically relevant pancreatic fistula after pancreaticoduodenectomy?--an analysis in 244 consecutive patients.

Kawai M, Tani M, Hirono S, Ina S, Miyazawa M, Yamaue H.

World J Surg. 2009 Dec;33(12):2670-8. doi: 10.1007/s00268-009-0220-2.

PMID:
19774410
21.

A central pancreatectomy for benign or low-grade malignant neoplasms.

Hirono S, Tani M, Kawai M, Ina S, Nishioka R, Miyazawa M, Shimizu A, Uchiyama K, Yamaue H.

J Gastrointest Surg. 2009 Sep;13(9):1659-65. doi: 10.1007/s11605-009-0934-3. Epub 2009 Jun 2.

PMID:
19488821
22.

A pancreaticoduodenectomy is acceptable for periampullary tumors in the elderly, even in patients over 80 years of age.

Tani M, Kawai M, Hirono S, Ina S, Miyazawa M, Nishioka R, Shimizu A, Uchiyama K, Yamaue H.

J Hepatobiliary Pancreat Surg. 2009;16(5):675-80. doi: 10.1007/s00534-009-0106-6. Epub 2009 Apr 22.

PMID:
19387530
23.

Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.

Hirono S, Tani M, Kawai M, Ina S, Nishioka R, Miyazawa M, Fujita Y, Uchiyama K, Yamaue H.

Arch Surg. 2009 Apr;144(4):345-9; discussion 349-50. doi: 10.1001/archsurg.2009.2.

PMID:
19380648
24.

Pylorus-preserving pancreaticoduodenectomy versus conventional pancreaticoduodenectomy for pancreatic adenocarcinoma.

Tani M, Kawai M, Hirono S, Ina S, Miyazawa M, Fujita Y, Uchiyama K, Yamaue H.

Surg Today. 2009;39(3):219-24. doi: 10.1007/s00595-008-3847-y. Epub 2009 Mar 12.

PMID:
19280281
25.

Xanthogranulomatous cholecystitis: the use of preoperative CT findings to differentiate it from gallbladder carcinoma.

Uchiyama K, Ozawa S, Ueno M, Hayami S, Hirono S, Ina S, Kawai M, Tani M, Yamaue H.

J Hepatobiliary Pancreat Surg. 2009;16(3):333-8. doi: 10.1007/s00534-009-0067-9. Epub 2009 Mar 12.

PMID:
19280109
26.

Phase 2 trial of oral S-1 combined with low-dose cisplatin for unresectable advanced pancreatic cancer.

Ina S, Tani M, Kawai M, Hirono S, Miyazawa M, Nishioka R, Fujita Y, Yamaue H.

Anticancer Res. 2008 Jul-Aug;28(4C):2373-7.

27.

A collision tumor composed of cancers of the bile duct and ampulla of Vater--immunohistochemical analysis of a rare entity of double cancer.

Hirono S, Tani M, Terasawa H, Kawai M, Ina S, Uchiyama K, Nakamura Y, Kakudo K, Yamaue H.

Hepatogastroenterology. 2008 May-Jun;55(84):861-4.

PMID:
18705284
28.

Liver metastasis as an initial recurrence has no impact on the survival of patients with resectable pancreatic adenocarcinoma.

Tani M, Kawai M, Miyazawa M, Hirono S, Ina S, Nishioka R, Fujita Y, Uchiyama K, Yamaue H.

Langenbecks Arch Surg. 2009 Mar;394(2):249-53. doi: 10.1007/s00423-008-0296-4. Epub 2008 Mar 15.

PMID:
18343944
29.

Prognostic factors for long-term survival in patients with locally invasive pancreatic cancer.

Tani M, Kawai M, Terasawa H, Ina S, Hirono S, Shimamoto T, Miyazawa M, Uchiyama K, Yamaue H.

J Hepatobiliary Pancreat Surg. 2007;14(6):545-50. Epub 2007 Nov 30.

PMID:
18040618
30.

CLIP method (preoperative CT image-assessed ligation of inferior pancreaticoduodenal artery) reduces intraoperative bleeding during pancreaticoduodenectomy.

Kawai M, Tani M, Ina S, Hirono S, Nishioka R, Miyazawa M, Uchiyama K, Shimamoto T, Yamaue H.

World J Surg. 2008 Jan;32(1):82-7.

PMID:
18027017
31.
32.

Does postoperative chemotherapy have a survival benefit for patients with pancreatic cancer?

Tani M, Kawai M, Terasawa H, Ina S, Hirono S, Uchiyama K, Yamaue H.

J Surg Oncol. 2006 May 1;93(6):485-90.

PMID:
16615151
33.

Indication of hepatopancreatoduodenectomy for biliary tract cancer.

Hirono S, Tani M, Kawai M, Ina S, Uchiyama K, Yamaue H.

World J Surg. 2006 Apr;30(4):567-73; discussion 574-5.

PMID:
16568228
34.

Improvement of delayed gastric emptying in pylorus-preserving pancreaticoduodenectomy: results of a prospective, randomized, controlled trial.

Tani M, Terasawa H, Kawai M, Ina S, Hirono S, Uchiyama K, Yamaue H.

Ann Surg. 2006 Mar;243(3):316-20.

35.

Complications with reconstruction procedures in pylorus-preserving pancreaticoduodenectomy.

Tani M, Kawai M, Terasawa H, Ueno M, Hama T, Hirono S, Ina S, Uchiyama K, Yamaue H.

World J Surg. 2005 Jul;29(7):881-4.

PMID:
15951940
36.

In vivo transfer of TGF-alpha and beta genes to keratinocytes.

Sawamura D, Ina S, Goto M, Akiyama M, Shimizu H.

J Dermatol Sci. 2004 May;34(3):234-6. No abstract available.

PMID:
15113594
37.

Virus-associated hemophagocytic syndrome and hemorrhagic jejunal ulcer caused by cytomegalovirus infection in a non-compromised host; a case report of unusual entity.

Ina S, Tani M, Takifuji K, Yamazoe S, Nakatani Y, Yamaue H.

Hepatogastroenterology. 2004 Mar-Apr;51(56):491-3.

PMID:
15086189
38.

Expression of the mouse Aven gene during spermatogenesis, analyzed by subtraction screening using Mvh-knockout mice.

Ina S, Tsunekawa N, Nakamura A, Noce T.

Gene Expr Patterns. 2003 Oct;3(5):635-8.

PMID:
12971998
39.

Keratinocyte gene therapy: cytokine gene expression in local keratinocytes and in circulation by introducing cytokine genes into skin.

Meng X, Sawamura D, Ina S, Tamai K, Hanada K, Hashimoto I.

Exp Dermatol. 2002 Oct;11(5):456-61.

PMID:
12366699
40.

A broad replication origin of Drosophila melanogaster, oriDalpha, consists of AT-rich multiple discrete initiation sites.

Ina S, Sasaki T, Yokota Y, Shinomiya T.

Chromosoma. 2001 Feb;109(8):551-64. Erratum in: Chromosoma 2001 May;110(2):131.

PMID:
11305788
41.

Expression vector with DNA of bovine papilloma virus 1 for keratinocyte gene therapy.

Sawamura D, Meng X, Ina S, Kon A, Tamai K, Ohe Y, Hashimoto I.

J Dermatol Sci. 2000 Jun;23(2):111-6.

PMID:
10808128
42.

In vivo gene transfer method in keratinocyte gene therapy: intradermal injection of DNA complexed with high mobility group-1 protein in rats.

Ina S, Sawamura D, Meng X, Tamai K, Hanada K, Hashimoto I.

Acta Derm Venereol. 2000 Jan-Feb;80(1):10-3.

43.

The Surface Structure of Hydroxyapatite Single Crystal and the Accumulation of Arachidic Acid.

Sato K, Suetsugu Y, Tanaka J, Ina S, Monma H.

J Colloid Interface Sci. 2000 Apr 1;224(1):23-27.

PMID:
10708490
44.

Transgenic TNF-alpha causes apoptosis in epidermal keratinocytes after subcutaneous injection of TNF-alpha DNA plasmid.

Meng X, Sawamura D, Baba T, Ina S, Ita K, Tamai K, Hanada K, Hashimoto I.

J Invest Dermatol. 1999 Nov;113(5):856-7. No abstract available.

45.

In vivo gene introduction into keratinocytes using jet injection.

Sawamura D, Ina S, Itai K, Meng X, Kon A, Tamai K, Hanada K, Hashimoto I.

Gene Ther. 1999 Oct;6(10):1785-7.

46.
47.

Promoter/enhancer cassettes for keratinocyte gene therapy.

Sawamura D, Meng X, Ina S, Nakano H, Tamai K, Nomura K, Hanada K, Miyazaki JI, Hashimoto I.

J Invest Dermatol. 1999 May;112(5):828-30. No abstract available.

49.

In vivo transfer of a foreign gene to keratinocytes using the hemagglutinating virus of Japan-liposome method.

Sawamura D, Meng X, Ina S, Ishikawa H, Tamai K, Nomura K, Hanada K, Hashimoto I, Kaneda Y.

J Invest Dermatol. 1997 Feb;108(2):195-9.

Supplemental Content

Support Center